ID CLPT1_MOUSE Reviewed; 664 AA. AC Q8VBZ3; O08708; Q3U758; Q3U823; Q3UG77; Q8VEJ6; DT 11-JUL-2006, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2002, sequence version 1. DT 27-MAR-2024, entry version 128. DE RecName: Full=Putative lipid scramblase CLPTM1 {ECO:0000250|UniProtKB:O96005}; DE AltName: Full=Cleft lip and palate transmembrane protein 1 homolog; DE AltName: Full=Thymic epithelial cell surface antigen {ECO:0000303|PubMed:9218588}; GN Name=Clptm1; Synonyms=N14; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY. RC STRAIN=BALB/cJ; TISSUE=Thymus; RX PubMed=9218588; RA Takeuchi T., Kuro-o M., Miyazawa H., Ohtsuki Y., Yamamoto H.; RT "Transgenic expression of a novel thymic epithelial cell antigen stimulates RT aberrant development of thymocytes."; RL J. Immunol. 159:726-733(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Bone marrow; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Mammary tumor, and Salivary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION. RX PubMed=9828125; DOI=10.1006/geno.1998.5577; RA Yoshiura K., Machida J., Daack-Hirsch S., Patil S.R., Ashworth L.K., RA Hecht J.T., Murray J.C.; RT "Characterization of a novel gene disrupted by a balanced chromosomal RT translocation t(2;19)(q11.2;q13.3) in a family with cleft lip and palate."; RL Genomics 54:231-240(1998). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP FUNCTION. RX PubMed=29395912; DOI=10.1016/j.neuron.2017.12.038; RA Ge Y., Kang Y., Cassidy R.M., Moon K.M., Lewis R., Wong R.O.L., RA Foster L.J., Craig A.M.; RT "Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory RT Synaptic Strength."; RL Neuron 97:596-610(2018). CC -!- FUNCTION: Involved in GABAergic but not glutamatergic transmission CC (PubMed:29395912). Binds and traps GABAA receptors in the endoplasmic CC reticulum (ER) (PubMed:29395912). Modulates postsynaptic GABAergic CC transmission, and therefore inhibitory neurotransmission, by reducing CC the plasma membrane expression of these receptors (PubMed:29395912). CC Altered GABAergic signaling is one among many causes of cleft palate CC (PubMed:29395912). Might function as a lipid scramblase, translocating CC lipids in membranes from one leaflet to the other one (By similarity). CC Required for efficient glycosylphosphatidylinositol (GPI) inositol CC deacylation in the ER, which is a crucial step to switch GPI-anchored CC proteins (GPI-APs) from protein folding to transport states (By CC similarity). May play a role in T-cell development (PubMed:9218588). CC {ECO:0000250|UniProtKB:O96005, ECO:0000250|UniProtKB:Q96KA5, CC ECO:0000269|PubMed:29395912, ECO:0000269|PubMed:9218588, CC ECO:0000303|PubMed:29395912}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane CC protein {ECO:0000305|PubMed:9828125}. CC -!- TISSUE SPECIFICITY: Widely expressed (PubMed:9218588, PubMed:9828125). CC Expressed by subcapsular and outer cortical thymic cells CC (PubMed:9218588). {ECO:0000269|PubMed:9218588, CC ECO:0000269|PubMed:9828125}. CC -!- DEVELOPMENTAL STAGE: Ubiquitously expressed in mouse embryo. CC {ECO:0000269|PubMed:9828125}. CC -!- MISCELLANEOUS: Mice overexpressing Clptm1 exhibit an aberrant CC development of thymocytes. CC -!- SIMILARITY: Belongs to the CLPTM1 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA19836.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D67067; BAA19836.1; ALT_FRAME; mRNA. DR EMBL; AK148080; BAE28332.1; -; mRNA. DR EMBL; AK152410; BAE31196.1; -; mRNA. DR EMBL; AK152809; BAE31514.1; -; mRNA. DR EMBL; BC018389; AAH18389.1; -; mRNA. DR EMBL; BC022172; AAH22172.1; -; mRNA. DR CCDS; CCDS39800.1; -. DR RefSeq; NP_062623.2; NM_019649.2. DR AlphaFoldDB; Q8VBZ3; -. DR BioGRID; 207996; 5. DR STRING; 10090.ENSMUSP00000051293; -. DR GlyConnect; 2218; 7 N-Linked glycans (2 sites). DR GlyCosmos; Q8VBZ3; 6 sites, 7 glycans. DR GlyGen; Q8VBZ3; 6 sites, 7 N-linked glycans (2 sites). DR iPTMnet; Q8VBZ3; -. DR PhosphoSitePlus; Q8VBZ3; -. DR SwissPalm; Q8VBZ3; -. DR EPD; Q8VBZ3; -. DR jPOST; Q8VBZ3; -. DR MaxQB; Q8VBZ3; -. DR PaxDb; 10090-ENSMUSP00000051293; -. DR PeptideAtlas; Q8VBZ3; -. DR ProteomicsDB; 285493; -. DR Pumba; Q8VBZ3; -. DR Antibodypedia; 31237; 190 antibodies from 29 providers. DR DNASU; 56457; -. DR Ensembl; ENSMUST00000055242.11; ENSMUSP00000051293.10; ENSMUSG00000002981.11. DR GeneID; 56457; -. DR KEGG; mmu:56457; -. DR UCSC; uc009fmq.1; mouse. DR AGR; MGI:1927155; -. DR CTD; 1209; -. DR MGI; MGI:1927155; Clptm1. DR VEuPathDB; HostDB:ENSMUSG00000002981; -. DR eggNOG; KOG2489; Eukaryota. DR GeneTree; ENSGT00530000063461; -. DR HOGENOM; CLU_019907_3_1_1; -. DR InParanoid; Q8VBZ3; -. DR OMA; TLWAHFY; -. DR OrthoDB; 31537at2759; -. DR PhylomeDB; Q8VBZ3; -. DR TreeFam; TF318501; -. DR BioGRID-ORCS; 56457; 13 hits in 79 CRISPR screens. DR ChiTaRS; Clptm1; mouse. DR PRO; PR:Q8VBZ3; -. DR Proteomes; UP000000589; Chromosome 7. DR RNAct; Q8VBZ3; Protein. DR Bgee; ENSMUSG00000002981; Expressed in embryonic brain and 261 other cell types or tissues. DR GO; GO:0012505; C:endomembrane system; IBA:GO_Central. DR GO; GO:0009897; C:external side of plasma membrane; IDA:BHF-UCL. DR GO; GO:0098982; C:GABA-ergic synapse; ISO:MGI. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0050811; F:GABA receptor binding; IDA:UniProtKB. DR GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW. DR GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; ISO:MGI. DR GO; GO:0033081; P:regulation of T cell differentiation in thymus; IMP:BHF-UCL. DR InterPro; IPR008429; CLPTM1. DR PANTHER; PTHR21347; CLEFT LIP AND PALATE ASSOCIATED TRANSMEMBRANE PROTEIN-RELATED; 1. DR PANTHER; PTHR21347:SF14; CLEFT LIP AND PALATE TRANSMEMBRANE PROTEIN 1; 1. DR Pfam; PF05602; CLPTM1; 1. DR Genevisible; Q8VBZ3; MM. PE 1: Evidence at protein level; KW Acetylation; Developmental protein; Differentiation; Glycoprotein; KW Membrane; Phosphoprotein; Reference proteome; Transmembrane; KW Transmembrane helix. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:O96005" FT CHAIN 2..664 FT /note="Putative lipid scramblase CLPTM1" FT /id="PRO_0000245097" FT TOPO_DOM 2..354 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 355..375 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 376..390 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 391..411 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 412..416 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 417..437 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 438..477 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 478..498 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 499..502 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 503..523 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 524..664 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 1..51 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 618..664 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 19..38 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 618..649 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:O96005" FT MOD_RES 601 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O96005" FT CARBOHYD 28 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 119 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 161 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 241 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 295 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 413 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CONFLICT 161 FT /note="N -> Y (in Ref. 2; BAE28332)" FT /evidence="ECO:0000305" FT CONFLICT 470 FT /note="V -> A (in Ref. 2; BAE31514)" FT /evidence="ECO:0000305" SQ SEQUENCE 664 AA; 75291 MW; 6F78F58549CC7EE1 CRC64; MAAAQEADGA GSAVVAAGGG SSGQVTSNGS IGRDTPAETQ PQNPPPQPAP NAWQVIKGVL FRIFIIWAIS SWFRRGPSPQ DQSGPGGAPR VASRNLFPKD TLMNLHVYIS EHEHFTDFNA TSALFWEQHD LVYGDWTSGE NSDGCYEHFA ELDIPQSVQQ NGSIYIHVYF TKSGFHPDPR QKALYRRLAT VHMSRMINKY KRRRFQKTKN LLTGETEADP EMIKRAEDYG PVEVISHWHP NITINIVDDH TPWVKGSVPP PLDQYVKFDA VSGDYYPIIY FNDYWNLQKD YYPINESLAS LPLRVSFCPL SLWRWQLYAA QSTKSPWNFL GDELYEQSDE EQDSVKVALL ETSPYLLALT IIVSIVHSVF EFLAFKNDIQ FWNSRQSLEG LSVRSVFFGV FQSFVVLLYI LDNETNFVVQ VSVFIGVLID LWKITKVMDV RLDREHRVAG IFPCPTFKDK STYIESSTKV YDDMAFRYLS WILFPLLGCY AVYSLLYLEH KGWYSWVLSM LYGFLLTFGF ITMTPQLFIN YKLKSVAHLP WRMLTYKALN TFIDDLFAFV IKMPVMYRIG CLRDDVVFFI YLYQRWIYRV DPTRVNEFGM SGEDVSAAAS RAQASTAAGA LTPAPSTAVS GEDASTVPKA TSGACTASQP QEAPPKPAED KKKD //